Andy Hope, Ph.D.

Andy Hope, Ph.D. has a diverse range of work experience in the fields of business development, sales, and strategic alliances, primarily within the life sciences and healthcare industries. Andy has held various roles at companies such as Rancho BioSciences, Cyclica Inc., BioReference Labs/GeneDx, Thomson Reuters, GeneGo Inc., IBM, GeneFormatics, Aspen Technology, Biosym Technologies, and Biosym.

At Rancho BioSciences, Dr. Hope worked as part of a team of experienced scientists, providing high-quality data curation and knowledge mining services to support research efforts in the life sciences community.

As VP of Business Development at Cyclica Inc., they played a key role in developing strategic partnerships for the company.

During their time at BioReference Labs/GeneDx, Dr. Hope was responsible for developing collaborative partnerships in drug discovery and clinical development, leveraging the company's expertise in next-generation sequencing technologies and genomic assets to support precision medicine efforts.

At Thomson Reuters, they led a team of solution and sales specialists, supporting various customers in both the life sciences and healthcare sectors. This included assisting pharma/biotech customers in applying network biology approaches and aiding healthcare providers and diagnostics companies in interpreting patient genomic information.

Dr. Hope also held roles at GeneGo Inc. and IBM, where they focused on business development activities within the life sciences and healthcare industries.

Throughout their career, Dr. Hope has demonstrated a strong background in sales and business development, as well as a deep understanding of various technologies and applications within the life sciences and healthcare fields.

Andy Hope, Ph.D. pursued their education at UCL from 1979 to 1985, where they obtained a Ph.D. in Chemistry. Prior to this, they attended Morriston Comprehensive, although specific details about their degree or field of study were not provided.